# Coya Therapeutics, Inc.: Form 8-K, filed Jan 20, 2026

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 8-K
- Filed: 2026-01-20
- Accepted by EDGAR: Jan 20, 2026, 13:20 ET
- Period: 2026-01-20
- Accession: 0001193125-26-016017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000119312526016017/d48170d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000119312526016017/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000119312526016017/d48170d8k.htm

Filed Jan 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-016017. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.